Carregant...
Hepatitis C Treatment in Patients with Porphyria Cutanea Tarda
BACKGROUND AND AIM: Hepatitis C virus (HCV) infection is a common susceptibility factor for porphyria cutanea tarda (PCT). Experience on HCV treatment in PCT patients is limited. Recently, HCV treatment has improved with direct acting antivirals (DAA). We review our experience on HCV treatment in PC...
Guardat en:
| Publicat a: | Am J Med Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5484053/ https://ncbi.nlm.nih.gov/pubmed/28641714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjms.2017.03.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|